Comparison of Strategies for Vascular Access Closure After Transcatheter Aortic Valve Implantation: The ACCESS-TAVI Randomized Trial

Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients:

• Consultant Fee/Honoraria/Speaker's Bureau - AstraZenca; Abbott; SIS Medical; Translumina
• Grant Support/Research Contract - Boston Scientific Corporation; Boehringer Ingelheim